跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,730 条关于
“MSI tumors”
全部
29,730
临床试验
22,993
药物
884
机构
117
资讯
5,736
去年
Nimbus Therapeutics Initiates First-in-Human Trial of NDI-219216 for MSI-H Tumors Resistant to Standard Therapies
9个月前
Nimbus Therapeutics Completes Dose Escalation for Novel WRN Inhibitor NDI-219216 in MSI-H Tumors
去年
Nouscom Completes Enrollment in Phase 2 Trial of NOUS-209 for MSI Metastatic Colorectal Cancer
去年
NGS Demonstrates High Concordance with IHC for MSI Assessment in Solid Tumors
去年
IDEAYA Biosciences' Werner Helicase Inhibitor IDE275 Cleared for Phase 1 Trial in MSI-High Solid Tumors
10个月前
WRN Inhibitors Enter Clinical Development Phase as Precision Oncology Market Expands
去年
MOMA Therapeutics Initiates First-in-Human Trial of Werner Helicase Inhibitor MOMA-341 for MSI-H Solid Tumors
去年
IDEAYA's WRN Inhibitor IDE275 Shows Promise for MSI-H Cancers, Featured in AACR 2025 Oral Presentation
去年
Novartis' Oral WRN Helicase Inhibitor HRO761 Targets MSI-High and dMMR Tumors
2年前
Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial
第 1 页,共 574 页
上一页
下一页